Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older

Abstract Background It is estimated that approximately 50% of patients with hepatitis C virus (HCV) infection in Japan are currently over 75 years old. However, patients aged ≥ 75 years are typically underrepresented in clinical trials of direct-acting antivirals. This study aimed to evaluate the ef...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Yuri Komaki, Yoshinori Ozono, Kenichi Nakamura, Hisayoshi Iwakiri, Satoru Hasuike, Mitsue Sueta, Tadashi Miike, Shojiro Yamamoto, Hirofumi Uto, Kazunori Kusumoto, Toshimasa Ochiai, Junya Kato, Naoto Komada, Kazuo Kuroki, Toshiharu Eto, Masafumi Shigehira, Shuichi Hirono, Kenji Nagata, Hiroshi Kawakami
格式: Artigo
語言:Inglês
出版: BMC 2022-04-01
叢編:BMC Gastroenterology
主題:
Chronic hepatitis C
Direct-acting antivirals
Glecaprevir
Pibrentasvir
Sustained virological response
在線閱讀:https://doi.org/10.1186/s12876-022-02284-z
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍